Frontlight ResearchEarly access
Fabry disease trials in United Kingdom
3 of 7 trials · From ClinicalTrials.gov, checked 18 November 2026. Ask the study team whether a trial fits you.
- Phase 3Not yet taking people in United KingdomA Study to Learn How Well Lucerastat Works and How Safe it is in Untreated Adult Male Participants With Fabry Disease
- Where
- London, Salford
- Age
- 18 years to 60 years
- People
- 16 worldwide
- Run by
- Idorsia Pharmaceuticals Ltd.
See details and how to joinNCT07778667 · EU 2026-525207-27-00 - Phase 3Taking peopleA Study of Migalastat in Pediatric Subjects (2 to <12 Yrs) With Fabry Disease and Amenable GLA Variants
- Where
- London, Manchester
- Age
- 2 years to 11 years
- People
- 8 worldwide
- Run by
- Amicus Therapeutics
See details and how to joinNCT06904261 - Phase 2/3Not yet taking people in United KingdomA Study to Learn About the Safety and Effects of the Study Drug PRX-102 in Children and Adolescents With Fabry Disease
- Where
- London
- Age
- 2 years to 17 years
- People
- 22 worldwide
- Run by
- Chiesi Farmaceutici S.p.A.
See details and how to joinNCT06328608 · EU 2022-503128-29-00